Abstract
Pseudoephedrine (PSE) is a common sympathomimetic stimulant that is prohibited in large doses (> 150 µg·mL-1) by the World Anti-Doping Agency (WADA) yet unrestricted by the National Collegiate Athletic Association (NCAA). PURPOSE: To investigate the effect of body weight dosing of PSE on 800-m run times of NCAA female runners. METHODS: NCAA female track and field runners (N = 15) volunteered for a randomized, double-blind, crossover design. Runners were administered both a placebo and 2.5 mg·kg-1 PSE a week apart. Ninety minutes post-ingestion, participants completed an 800-m individual time trial on an indoor track. Finishing time was recorded with an automated video timing device. Placebo and PSE running times were compared using a paired t-test. RESULTS: Fourteen runners completed both trials and one was an outlier; N = 13. Despite being dosed (144 mg ± 17 mg) well above normal therapeutic levels, there was no significant difference (p = 0.92) in 800-m times between the placebo (2:39.372 ± 9.636) and PSE (2:39.447 ± 9.584) trials. CONCLUSION: A 2.5 mg·kg-1 dose of PSE had no effect on 800-m run times. This raises the question as to why PSE is a specified prohibited substance by WADA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
